Bristol-Myers Squibb Co.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2010
Total Assets: $31.08B
Liabilities Breakdown FY2010
Total Liabilities: $15.44B
Asset Breakdown
Total Assets: $31.08B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $5.03B | 16.2% |
| Accounts Receivable | $1.99B | 6.4% |
| Inventory | $1.20B | 3.9% |
| Property, Plant & Equipment | $4.66B | 15.0% |
| Goodwill | $5.23B | 16.8% |
| Intangible Assets | $3.37B | 10.8% |
| Other Assets | $9.59B | 30.9% |
Liabilities Breakdown
Total Liabilities: $15.44B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.98B | 12.8% |
| Long-Term Debt | $5.33B | 34.5% |
| Other Liabilities | $8.13B | 52.6% |